Micromed

Natus Medical today announced it completed the previously announced acquisition of Micromed Holdings.

The deal, announced in December 2022, will add Micromed’s neurophysiology solutions to Natus Medical’s offerings. The financial details of the acquisition were not disclosed.

The Micromed acquisition is the first transaction made by the Middleton, Wisconsin-based company since its $1.2 billion acquisition by the ArchiMed group in July 2022.

“We are thrilled to complete this deal and move forward combining the Natus and Micromed teams and product portfolios,” Natus President Austin Noll said in a news release. “Together, we will be able to provide our neuroscience customers a more comprehensive product offering and unrivaled global service and support through the increased breadth and depth of our combined resources.”

Natus Medical has specialized in 85 years of neurodiagnostic leadership. Micromed’s portfo…

Natus Medical announced today that it entered into a definitive agreement to acquire neurophysiology solution provider Micromed.

Middleton, Wisconsin-based Natus expects the transaction to close in early 2023. The company elected to not disclose the financial terms for the deal. It marks the first transaction made by the company since its $1.2 billion acquisition by the ArchiMed group in July.

“We are pleased to make this first growth-oriented investment as an ArchiMed portfolio company,” said Thomas J. Sullivan, Natus CEO. “The breadth and depth of clinical expertise in Natus and Micromed will enable us to bring exciting innovation to our neuroscience customers and their patients around the globe.”

The company plans to join with Micromed to provide a best-in-class portfolio of neurodiagnostic and neuromonitoring solutions. Micromed’s offerings include Brain Quick, MyoQuick, NeuroWerk, SleepRT and Moberg. Natus expects those…